CION Ameerpet
Ovarian cancer is diagnosed differently from most cancers. There is often no biopsy first — the definitive answer comes from tissue removed at surgery, and there is a specific reason for that which is worth understanding.
For most cancers the sequence is familiar: something is found, a needle biopsy takes a sample, pathology gives a diagnosis, and treatment is planned around it. Diagnosis first, treatment second. It is how breast, lung, prostate and most other cancers are handled.
Ovarian cancer usually does not work that way, and the reason is mechanical. An ovarian tumour that is still contained within the ovary is at an early stage, and early stage is precisely where outcomes are best. Pushing a needle through the capsule to sample it risks spilling malignant cells into the abdominal cavity — potentially converting a contained, curable cancer into a disseminated one.
So in a woman with an operable suspicious mass, the standard approach is to remove it intact and let the pathologist examine the whole thing. That single operation does both jobs: it establishes the diagnosis and it treats the disease. It is a genuine departure from how cancer is usually diagnosed, and it explains a great deal about why this pathway feels unfamiliar.
For most cancers, a needle sample gives the diagnosis before any treatment is planned.
Puncturing a contained ovarian tumour can spill malignant cells into the abdomen.
The same operation removes the mass intact and provides the tissue that confirms what it is.
Ovarian cancer is staged surgically, not radiologically. Unlike many cancers where a scan determines the stage, ovarian cancer staging requires systematic sampling during the operation — washings from the abdominal cavity, biopsies of the peritoneal surfaces, omentum, and lymph nodes, even where everything looks normal to the eye. This matters because microscopic disease found in those samples changes the stage, and therefore changes the treatment. It is also why who performs the first operation matters: an incompletely staged operation may need to be repeated, and outcomes are better where staging surgery is done properly the first time. Source: FIGO ovarian cancer staging; NCCN Ovarian Cancer guidelines.
Most women move through this over a few weeks. Knowing the order is the single most useful thing during the waiting.
A detailed symptom history — which of the four symptoms, since when, how many days a month — alongside abdominal and pelvic examination looking for a mass, distension and free fluid. Family history of ovarian, breast, bowel and endometrial cancer on both sides. This directs everything that follows.
The first and most informative test. A transvaginal scan characterises the ovaries in detail — size, contents, wall regularity, solid components, papillary projections and internal blood flow — while a transabdominal scan assesses the wider abdomen and detects free fluid. See what the ultrasound shows.
CA-125 where an epithelial tumour is the consideration, interpreted alongside the scan and your menopausal status rather than alone. In women under 40, germ cell markers including AFP, beta-hCG and LDH are added, because different tumour types predominate at that age. See germ cell markers.
The imaging features, marker results and menopausal status are combined into a risk assessment — commonly the Risk of Malignancy Index — which determines whether care stays local or moves to a specialist gynaecologic-oncology service. It is a triage tool for reaching the right team, not a diagnosis. See the RMI.
A CT scan of the chest, abdomen and pelvis maps the extent of disease and helps plan the operation — how much is present, where, and whether complete removal looks achievable. An MRI is used instead where the question is the nature of an indeterminate mass rather than the extent of disease.
The mass is removed intact where possible, and systematic staging samples are taken. A frozen section during the operation can give a preliminary answer that guides how extensive the surgery should be. Final histopathology follows over one to two weeks and is the definitive diagnosis. At CION this surgery is coordinated with specialist gynaecologic-oncology partner centres and may be billed there.
The no-biopsy principle applies to operable disease. There are clear situations where sampling first is the right approach.
Where imaging shows extensive disease that could not be completely removed at an initial operation, the approach changes. Chemotherapy is given first to shrink the disease, with surgery following — an approach called neoadjuvant chemotherapy with interval debulking.
Because chemotherapy cannot be started without knowing what is being treated, a tissue diagnosis is needed first. Here an image-guided biopsy is appropriate: the concern about spreading a contained tumour does not apply when disease is already widespread. See debulking surgery.
Not every abdominal mass with ascites is ovarian cancer. Abdominal tuberculosis can produce an almost identical picture including a raised CA-125, and it is entirely treatable with medication rather than surgery. Lymphoma, and cancers spreading from the stomach or bowel, can also present this way.
Where the differential is genuinely open, a tissue diagnosis before committing to major surgery is the right decision — because the treatments for these conditions are completely different and operating on the wrong assumption helps nobody.
Where there is significant free fluid, a needle sample of it — an ascitic tap — is a straightforward outpatient procedure under local anaesthetic that can provide cells for examination without disturbing any contained mass.
It is also therapeutic where the volume of fluid is causing breathlessness or discomfort, since draining it provides immediate relief. Fluid is analysed for malignant cells, for protein and albumin, and where relevant for tuberculosis. See ascites.
Where a woman's general health means major surgery would carry unacceptable risk, treatment decisions must be made without an operation. A tissue diagnosis is then obtained by the least invasive route available, so that chemotherapy or other treatment can be given appropriately.
This is a judgement made with the whole picture — age, other medical conditions, and the woman's own priorities — and it is exactly the kind of decision a tumour board is designed to make rather than one clinician working alone.
A middle path that is often overlooked. Keyhole surgery allows the surgeon to see the abdominal cavity directly, assess how extensive disease is and whether complete removal is achievable, and take targeted biopsies under direct vision.
It is particularly useful where imaging is equivocal about whether upfront surgery would succeed. It avoids committing to a major operation that might not achieve its goal, while still giving a proper tissue diagnosis.
Where surgery does go ahead, a frozen section allows a pathologist to examine tissue while the operation is still under way and give a preliminary answer within minutes. This guides how extensive the surgery should be — whether to proceed to full staging, or to stop if the finding is benign.
It is preliminary rather than final. The definitive diagnosis comes from full histopathological examination over the following one to two weeks, and occasionally the final result differs from the frozen section. See reading a pathology report.
All reasonable, and several are rarely covered unless asked.
Staging and debulking outcomes are better with a specialist gynaecologic-oncology surgeon. It is fair to ask directly.
A multidisciplinary discussion before a plan is set is standard for suspected ovarian cancer, not an optional extra.
Washings, peritoneal biopsies, omentum and nodes, even where things look normal. An incompletely staged operation may need repeating.
This depends on whether complete removal looks achievable. Ask what the imaging suggested and why.
Offered to essentially all women with epithelial ovarian cancer, because it guides your own treatment. See BRCA testing.
Frozen section is preliminary. Ask when full histopathology is expected and how you will be told.
Where the first operation is done matters. Outcomes are better where staging and debulking are performed by a specialist gynaecologic-oncology surgeon — which is why CION coordinates this with specialist partner centres.
The hardest part of this period is usually not knowing what happens next or how long it takes. Forty-five minutes usually replaces that with a clear order of events.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them - together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
No referral needed and no cost for the first consultation. Bring your scan reports and blood results — together they map where you are in the pathway.
The period between a worrying scan and a definitive answer is the hardest part of this process for most women, and a large share of that difficulty is simply not knowing the sequence. Being told there will be a CT, then a discussion, then possibly surgery — with rough timings attached — changes the experience considerably even though it changes nothing clinically.
Your first consultation at CION is free and runs to about 45 minutes. Bring your scan reports and blood results. Much of the useful work is mapping where you actually are in the pathway, what the next step is for, and roughly how long it takes — and answering the questions people are often reluctant to ask, particularly about who will operate.
We should be clear about who does what. Chemotherapy and maintenance therapy, including PARP-inhibitor-class treatment, are delivered in-house at CION across 35+ centres in Telangana and Andhra Pradesh, as is genetic counselling and BRCA and HRD testing. Debulking and staging surgery is coordinated with specialist gynaecologic-oncology partner centres and may be billed there — we state that upfront rather than leaving it to be discovered later. Every case that raises a question is reviewed at a tumour board.
Free and unhurried. Long enough to map where you are, what comes next, and roughly when.
Multidisciplinary review — medical oncology, imaging and pathology — before a plan is set.
Staging and debulking performed at specialist gynaecologic-oncology partner centres and may be billed there.
Delivered across 35+ centres, so treatment can continue near where you live.
No single test gives the diagnosis. Each answers a different question and narrows what the next one needs to do.
| Step | The question it answers | What it cannot do |
|---|---|---|
| Ultrasound | What does the ovary look like, and is there free fluid? | Cannot give a tissue diagnosis or confirm malignancy. |
| CA-125 and markers | Do the blood results support or soften the imaging concern? | Not diagnostic. Raised in many benign conditions; normal in some cancers. |
| Risk score (RMI) | Should care stay local or move to a specialist service? | A triage tool, not a probability of cancer for you. |
| CT chest/abdomen/pelvis | How far does disease extend? Is complete removal achievable? | Poor at characterising the nature of a small adnexal mass. |
| MRI pelvis | Is this mass a dermoid, endometrioma or fibroid? | Not a staging test; does not assess the chest. |
| Frozen section | A preliminary answer while surgery is under way. | Preliminary only. The final diagnosis can differ. |
| Histopathology | The definitive diagnosis, subtype and grade. | Requires tissue, which usually means surgery. |
*In women under 40 the marker panel differs, since germ cell tumours rather than epithelial tumours are the main consideration at that age.
Because puncturing a contained ovarian tumour risks spilling malignant cells into the abdominal cavity, potentially converting a contained, curable early-stage cancer into a disseminated one. For most cancers a needle biopsy is the standard first step, but the ovary is different: an early tumour is still enclosed within the ovarian capsule, and that containment is precisely what makes the outlook good. So in a woman with an operable suspicious mass the standard approach is to remove it intact and let the pathologist examine the whole specimen, which establishes the diagnosis and treats the disease in one operation.
In several clear situations. Where imaging shows disease too extensive to remove completely at an initial operation, chemotherapy is given first — and that requires a tissue diagnosis, so an image-guided biopsy is appropriate since the concern about spreading a contained tumour no longer applies. A biopsy is also right where the diagnosis is genuinely uncertain, since abdominal tuberculosis, lymphoma and cancers spreading from elsewhere can mimic ovarian cancer and need completely different treatment. Sampling ascitic fluid, and diagnostic laparoscopy with targeted biopsies, are both used too.
It is a rapid pathological examination performed while the operation is still under way. A sample of tissue is frozen, sectioned and examined immediately, giving the surgeon a preliminary answer within minutes rather than days. That guides how extensive the surgery should be — whether to proceed to full staging and debulking, or to stop if the finding is benign. It is important to understand it is preliminary: the definitive diagnosis comes from full histopathological examination over the following one to two weeks, and occasionally the final result differs from the frozen section.
Because microscopic disease matters and scans cannot see it. Ovarian cancer spreads across the peritoneal surfaces, and deposits too small to appear on any imaging can still change the stage — and therefore the treatment. Proper staging requires systematic sampling during the operation: washings from the abdominal cavity, biopsies of the peritoneal surfaces, the omentum and lymph nodes, taken even where everything looks normal to the naked eye. This is also why who performs the first operation matters, since an incompletely staged operation may need to be repeated.
Most women move from a worrying scan to a definitive answer over a few weeks, though it varies. Ultrasound and blood tests are usually arranged quickly. A CT adds a short wait. Where surgery is the next step, scheduling depends on the service and on your fitness for the operation. The final histopathology result typically takes one to two weeks after surgery, with a preliminary frozen-section answer available on the day. If you feel the pathway has stalled, it is reasonable to ask where you are in it and what is next.
Yes, and it is one of the more important questions you can ask. Outcomes for ovarian cancer are better where staging and debulking surgery are performed by a specialist gynaecologic-oncology surgeon, because complete removal of visible disease and thorough systematic staging both strongly influence what treatment achieves. An incompletely staged operation may need to be repeated, which is worse for you in every respect. It is entirely reasonable to ask directly who will operate, what their specialty is, and whether your case has been discussed at a tumour board first.
The first consultation is free and runs to about 45 minutes — bring your scan reports and blood results so we can map where you are in the pathway. Debulking and staging surgery is coordinated with specialist gynaecologic-oncology partner centres and may be billed there, and we state that upfront rather than leaving it to be discovered later. Chemotherapy and maintenance therapy including PARP-inhibitor-class treatment are delivered in-house at CION across more than 35 centres, as are genetic counselling and BRCA and HRD testing. Every case that raises a question is reviewed at a tumour board.